Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 21841 - 21860 out of 485350 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 20 mg/mL oral liquid, 2 x 50 mL | Oral solution 20 mg per mL (as sulfate), 50 mL, 2, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 20 mg/mL oral liquid, 2 x 50 mL | Oral solution 20 mg per mL (as sulfate), 50 mL, 2, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 100 mg capsule, 56 | Capsule 100 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 100 mg capsule, 56 | Capsule 100 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 100 mg capsule, 56 | Capsule 100 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 100 mg capsule, 56 | Capsule 100 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 25 mg capsule, 56 | Capsule 25 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 25 mg capsule, 56 | Capsule 25 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 25 mg capsule, 56 | Capsule 25 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01EX12) larotrectinib (adm: O) | Vitrakvi 25 mg capsule, 56 | Capsule 25 mg (as sulfate), 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAustraliaLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab | Tecentriq SC 1.875 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection 1875 mg in 15 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheProductsPtyLtd |
Pages
